Nexvax-2

· ImmusanT, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nexvax-2, covering 2019-03-19 to 2019-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) [Phase 2]